Our colleagues Ewa Radziwon and Shaun Knights had a very productive few days at INDEX Nonwovens INDEX™26 in #Geneva, hosted by EDANA, the voice of nonwovens 🇨🇭 As the world’s leading nonwovens exhibition, it was important for Calla Lily Clinical Care to attend again: reconnecting with existing suppliers, meeting potential new partners, and exploring exciting …

It was recently World Clinical Trials Day, and our co-founder Lara took part in a special event hosted by SökerData and Covington & Burling LLP: 🔬 “Innovation in Action: Successful Women’s Clinical Trial Case Studies” 🧪 Lara shared the context, design and exciting early progress of our ongoing FREEDOM clinical trial evaluating Callavid® for threatened …

Original article here Calla Lily Clinical Care begins dosing in trial of intravaginal platform for threatened miscarriage by John Pinching | 7th May 2026 | News Nihr‑funded phase 2 study to assess progesterone delivery using Callavid device Calla Lily Clinical Care has dosed the first patients in its Freedom clinical trial, a nihr‑funded study evaluating the company’s Callavid …

We are delighted and honoured that Callavid® has been named in this National Institute for Health and Care Research (NIHR) news story highlighting the role NIHR is playing in improving outcomes for women through the UK Government’s revised Women’s Health Strategy. 🇬🇧 As NIHR notes: “NIHR is funding ‘Callavid’ which if approved would be the …

Original article here by Ben Adams photo by TF-Images/Getty Images German Merck has set up a new collaboration with U.K. medtech company Calla Lily Clinical Care to work on its next-generation intravaginal drug delivery approach. London-based Calla Lily is working on several applications for its Callavid product, a tampon-shaped device that can be used as …

We were delighted to host Alex Zabala Findlay, our NIHR (National Institute for Health and Care Research) Programme Manager, for a highly productive visit to our labs. 🔬 As his first visit to our facilities, it was a great opportunity to showcase our bespoke equipment and laboratory capabilities, walk through the R&D challenges we’ve successfully …

✨ Big congratulations to our board advisor Prof/Dr Annalisa Jenkins OBE on being recognised in the King’s New Year Honour’s List! Over more than 25 years, Annalisa has been an outstanding leader in the life sciences– building and guiding teams that have successfully taken programmes from early scientific discovery through clinical development, regulatory approval, and …

Calla Lily Clinical Care is pleased to be heading back to San Francisco for the J.P. Morgan Healthcare Conference 🇺🇲 From January 12–15, we’ll be on the ground reconnecting with partners, meeting new collaborators, and sharing the continued progress of our Callavid® vaginal drug delivery platform. It’s always a valuable moment in the calendar to …

As we wrap up the year, Lara and I are feeling so grateful for this Calla Lily Clinical Care team and everything we’re building together. This photo was taken after our year-end festivities involving axe throwing (!) a well-earned chance to step away from the day-to-day and enjoy each other’s company (and a bit of friendly …

👏 CLCC is proud to share that we’ve successfully completed our ISO 9001 audit with *zero* major or minor non-conformities for the *third* year in a row. Quality has always been and will always be one of the core pillars of our company, and this result is a testament to the commitment, rigour, and consistency …